# Virtus LifeSci Biotech Clinical Trials ETF (BBC)

> Source: Nexqual · https://nexqual.com/BBC · data as of 2026-10-23 20:00 UTC · cite as "Nexqual, Virtus LifeSci Biotech Clinical Trials ETF (BBC), nexqual.com/BBC" · informational, not investment advice.

**Price:** USD 41.22 (-2.16% on the day) · last close of Oct 23, 2026; US market after hours, not a live price. Prev close 42.13 · day 40.7–41.22 · 52w 28.73–56.18 · market cap null · PCX

## Key facts
- Total return with dividends: 1Y +37.1% vs S&P 500 +13.4%; 5Y -4.2% vs S&P 500 +76.9%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | +37.1% | -4.2% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +37.3% | -0.9% |
| Volatility (annualized) | 37.6% | 39.2% |
| Max drawdown | -30.2% (Aug 2026→Oct 2026) | -67.3% (Nov 2021→Mar 2025) |

## Peers
BBP (Virtus Biotech ETF) USD 102.07 -1.82% · SBIO (ALPS Medical Breakthroughs ETF) USD 53.38 -2.14% · FBT (First Trust Amex Biotech Index ) USD 269.25 -1.26% · PBE (Invesco Biotechnology & Genome ) USD 98.72 -0.67% · PTH (Invesco Dorsey Wright Healthcar) USD 58.52 -0.67%

## More
Full page: https://nexqual.com/BBC · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Options: expected move (Cboe, 15-min delayed)

| Expiration | Days | ATM IV | Expected move |
|---|---|---|---|
| 2026-11-20 | 28 | 44.3% | ±10.0% |
| 2026-12-18 | 56 | 43.6% | ±13.6% |
| 2027-01-15 | 84 | 43.3% | ±16.5% |
| 2027-04-16 | 175 | 42.0% | ±23.3% |